Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadoaki Ohashi

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Cancer Discovery|May 16, 2012
A new target for therapy in squamous cell carcinoma of the lungKadoaki Ohashi, William Pao
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[Survival Mechanisms of Drug Tolerant Persister Cancer Cells against Targeted Anticancer Drugs]Masataka Taoka, Go Makimoto, Kadoaki Ohashi
Acta Medica Okayama|October 27, 2020
Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment StrategiesGo Makimoto, Kadoaki Ohashi, Yoshinobu Maeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Epidermal growth factor receptor tyrosine kinase inhibitor-resistant diseaseKadoaki Ohashi, Yosef E Maruvka, Franziska Michor, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|April 28, 2025
Olanzapine enabled rechallenge after lorlatinib-induced psychosis: A case reportAkiyoshi Yokode, Masaki Fujiwara, Yuko Nakamura, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to OsimertinibGo Makimoto, Kadoaki Ohashi, Satoru Senoo, et al.
Cancer Research|June 4, 2009
Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivoEiki Ichihara, Kadoaki Ohashi, Nagio Takigawa, et al.
Internal Medicine (Tokyo, Japan)|July 12, 2019
A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated MacrophagesHiromi Watanabe, Kadoaki Ohashi, Kazuya Nishii, et al.
Anticancer Research|January 12, 2007
Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabineKadoaki Ohashi, Katsuyuki Kiura, Nagio Takigawa, et al.
Journal of Clinical Pathology|December 5, 2019
Pilot evaluation of a HER2 testing in non-small-cell lung cancerKatsuyuki Hotta, Hiroyuki Yanai, Kadoaki Ohashi, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Cancer Discovery|May 16, 2012
A new target for therapy in squamous cell carcinoma of the lungKadoaki Ohashi, William Pao
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 22, 2024
[Survival Mechanisms of Drug Tolerant Persister Cancer Cells against Targeted Anticancer Drugs]Masataka Taoka, Go Makimoto, Kadoaki Ohashi
Acta Medica Okayama|October 27, 2020
Anaplastic Lymphoma Kinase Fusion: A Review of Therapeutic Drugs and Treatment StrategiesGo Makimoto, Kadoaki Ohashi, Yoshinobu Maeda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Epidermal growth factor receptor tyrosine kinase inhibitor-resistant diseaseKadoaki Ohashi, Yosef E Maruvka, Franziska Michor, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|April 28, 2025
Olanzapine enabled rechallenge after lorlatinib-induced psychosis: A case reportAkiyoshi Yokode, Masaki Fujiwara, Yuko Nakamura, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to OsimertinibGo Makimoto, Kadoaki Ohashi, Satoru Senoo, et al.
Cancer Research|June 4, 2009
Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivoEiki Ichihara, Kadoaki Ohashi, Nagio Takigawa, et al.
Internal Medicine (Tokyo, Japan)|July 12, 2019
A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated MacrophagesHiromi Watanabe, Kadoaki Ohashi, Kazuya Nishii, et al.
Anticancer Research|January 12, 2007
Successful treatment of a patient with gastric and duodenal metastases from large cell carcinoma of the lung with carboplatin and gemcitabineKadoaki Ohashi, Katsuyuki Kiura, Nagio Takigawa, et al.
Journal of Clinical Pathology|December 5, 2019
Pilot evaluation of a HER2 testing in non-small-cell lung cancerKatsuyuki Hotta, Hiroyuki Yanai, Kadoaki Ohashi, et al.
Pageof 13